pdufa date for tirzepatide 𝐀𝐩𝐫𝐢𝐥 𝟐𝟏: Here's a summary of this morning's most important biotech news Fresh from the biotech pipeline:

Semaglutide has a higher dose version (2.4 mg once weekly) that is specifically for obesity treatment and has shown significant weight loss effects

It presents an option for those concerned about gastrointestinal issues but carries a risk of liver damage if overused

Godala M, Gaszyska E, Walczak K, Maecka-Wojciesko E

This process is especially important during prolonged exercise when fatty acids become a primary fuel source

Pain or Tenderness at the Injection Spot Lipotropic injections are sent into the body through a needle, and following the injection, it is possible to experience some pain and tenderness at the point of injection